Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Fen Ning 1 Article
Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
Ziqian Li, Kaying Chan, Yifei Qi, Linlin Lu, Fen Ning, Mengling Wu, Haifang Wang, Yuan Wang, Shaohui Cai, Jun Du
Cancer Res Treat. 2018;50(3):894-907.   Published online September 18, 2017
DOI: https://doi.org/10.4143/crt.2017.356
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Cancer-associated fibroblasts (CAFs) activated by cancer cells has a central role in development and malignant biological behavior in colorectal cancer (CRC). Adult fibroblasts do not express Snail, but Snail-positive fibroblasts are discovered in the stroma of malignant CRC and reported to be the key role to chemoresistance. However, the reciprocal effect of CAFs expressed Snail to chemoresistance on CRC cells and the underlying molecular mechanisms are not fully characterized.
Materials and Methods
Snail-overexpressed 3T3 stable cell lines were generated by lipidosome and CT26 mixed with 3T3-Snail subcutaneous transplanted CRC models were established by subcutaneous injection. Cell Counting Kit-8, flow cytometry and western blotting assays were performed, and immunohistochemistry staining was studied. The cytokines participated in chemoresistance was validated with reverse transcriptase-polymerase chain reaction and heatmap.
Results
Snail-expression fibroblasts are discovered in human and mouse spontaneous CRCs. Overexpression of Snail induces 3T3 fibroblasts transdifferentiation to CAFs. CT26 co-cultured with 3T3-Snail resisted the impairment from 5-fluorouracil and paclitaxel in vitro. The subcutaneous transplanted tumor models included 3T3-Snail cells develop without restrictions even after treating with 5-fluorouracil or paclitaxel. Moreover, these chemoresistant processes may be mediated by CCL1 secreted by Snail-expression fibroblasts via transforming growth factor β/nuclear factor-κB signaling pathways.
Conclusion
Taken together, Snail-expressing 3T3 fibroblasts display CAFs properties that support 5-fluorouracil and paclitaxel chemoresistance in CRC via participation of CCL1 and suggest that inhibition of the Snail-expression fibroblasts in tumor may be a useful strategy to limit chemoresistance.

Citations

Citations to this article as recorded by  
  • Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
    Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, Heya Khatoon, Prashant Kumar, Himanshu Sharma, Ashish Garg, Shubneesh Kumar, Ushasi Das
    Advances in Cancer Biology - Metastasis.2024; 10: 100114.     CrossRef
  • Reduced chemokine C‐C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites
    Miku Iwata, Ryuma Haraguchi, Riko Kitazawa, Chihiro Ito, Kohei Ogawa, Yasutsugu Takada, Sohei Kitazawa
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Sensing antibody functions with a novel CCR8-responsive engineered cell
    Jianyu Hao, Yitong Lv, Xufeng Xiao, Lidan Li, Changyuan Yu
    Acta Biochimica Polonica.2024;[Epub]     CrossRef
  • Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing
    Pin Lyu, Xiaoming Gu, Fuqi Wang, Haifeng Sun, Quanbo Zhou, Shuaixi Yang, Weitang Yuan
    Biomarker Research.2024;[Epub]     CrossRef
  • Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer
    Samaneh Tokhanbigli, Mehra Haghi, Kamal Dua, Brian Gregory George Oliver
    Cancer Drug Resistance.2024;[Epub]     CrossRef
  • Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)
    Yan Liu, Jun Liang, Yanping Zhang, Qie Guo
    International Journal of Oncology.2024;[Epub]     CrossRef
  • Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
    Zengli Fang, Qingcai Meng, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Yingjun Zhao, Xianjun Yu, Si Shi
    Cancer Communications.2023; 43(1): 3.     CrossRef
  • Faeces from malnourished colorectal cancer patients accelerate cancer progression
    Xu Chao, Zhang Lei, Liu Hongqin, Wang Ziwei, Li Dechuan, Du Weidong, Xu Lu, Chen Haitao, Zhang Bo, Ju Haixing, Yao Qinghua
    Clinical Nutrition.2022; 41(3): 632.     CrossRef
  • Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
    Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui
    Seminars in Cancer Biology.2022; 86: 436.     CrossRef
  • Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
    Qianyu Wang, Xiaofei Shen, Gang Chen, Junfeng Du
    Cancers.2022; 14(12): 2928.     CrossRef
  • Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting
    Sonia Aristin Revilla, Onno Kranenburg, Paul J. Coffer
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
    Qian Zou, Xue Lei, Aijing Xu, Ziqi Li, Qinglian He, Xiujuan Huang, Guangxian Xu, Faqing Tian, Yuanlin Ding, Wei Zhu
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
    Charalampos Fotsitzoudis, Asimina Koulouridi, Ippokratis Messaritakis, Theocharis Konstantinidis, Nikolaos Gouvas, John Tsiaoussis, John Souglakos
    Cancers.2022; 14(18): 4394.     CrossRef
  • Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Luciana Mosca, Andrea Ilari, Francesco Fazi, Yehuda G. Assaraf, Gianni Colotti
    Drug Resistance Updates.2021; 54: 100742.     CrossRef
  • Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway
    Masataka Fujikawa, Yu-ichiro Koma, Masayoshi Hosono, Naoki Urakawa, Kohei Tanigawa, Masaki Shimizu, Takayuki Kodama, Hiroki Sakamoto, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
    The American Journal of Pathology.2021; 191(4): 686.     CrossRef
  • Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry
    Tomohiro Tanaka, Ren Nanamiya, Junko Takei, Takuro Nakamura, Miyuki Yanaka, Hideki Hosono, Masato Sano, Teizo Asano, Mika K. Kaneko, Yukinari Kato
    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.2021; 40(2): 65.     CrossRef
  • The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
    Yanghong Ni, Xiaoting Zhou, Jia Yang, Houhui Shi, Hongyi Li, Xia Zhao, Xuelei Ma
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications
    Longfei Deng, Nianfen Jiang, Jun Zeng, Yi Wang, Hongjuan Cui
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers
    Xiaoqun Lv, Guoxiong Xu
    World Journal of Gastrointestinal Oncology.2021; 13(11): 1648.     CrossRef
  • Guanylate‐binding protein‐2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel‐resistant colorectal cancer cells by interfering Wnt signaling
    Jing Wang, Hui Min, Bin Hu, Xiaorong Xue, Yufan Liu
    Journal of Cellular Biochemistry.2020; 121(2): 1250.     CrossRef
  • Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
    Nuray Erin, Jelena Grahovac, Anamaria Brozovic, Thomas Efferth
    Drug Resistance Updates.2020; 53: 100715.     CrossRef
  • Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
    Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, Donata Simińska, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(16): 5647.     CrossRef
  • 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
    Sabrina Blondy, Valentin David, Mireille Verdier, Muriel Mathonnet, Aurélie Perraud, Niki Christou
    Cancer Science.2020; 111(9): 3142.     CrossRef
  • Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
    Jose J.G. Marin, Rocio I.R. Macias, Maria J. Monte, Elisa Herraez, Ana Peleteiro-Vigil, Beatriz Sanchez de Blas, Paula Sanchon-Sanchez, Alvaro G. Temprano, Ricardo A. Espinosa-Escudero, Elisa Lozano, Oscar Briz, Marta R. Romero
    Cancers.2020; 12(9): 2605.     CrossRef
  • CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
    Jan Korbecki, Szymon Grochans, Izabela Gutowska, Katarzyna Barczak, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(20): 7619.     CrossRef
  • Human Adipose-Derived Mesenchymal Stem Cells-Derived Exosomal microRNA-19b Promotes the Healing of Skin Wounds Through Modulation of the CCL1/TGF-β Signaling Axis


    Guoxiu Cao, Bei Chen, Xian Zhang, Hongyun Chen
    Clinical, Cosmetic and Investigational Dermatology.2020; Volume 13: 957.     CrossRef
  • Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5
    Ziqian Li, Jiawang Zhou, Junjie Zhang, Shiying Li, Hongsheng Wang, Jun Du
    International Journal of Cancer.2019; 145(7): 1946.     CrossRef
  • Nodal Facilitates Differentiation of Fibroblasts to Cancer-Associated Fibroblasts that Support Tumor Growth in Melanoma and Colorectal Cancer
    Ziqian Li, Junjie Zhang, Jiawang Zhou, Linlin Lu, Hongsheng Wang, Ge Zhang, Guohui Wan, Shaohui Cai, Jun Du
    Cells.2019; 8(6): 538.     CrossRef
  • The multi-factorial nature of clinical multidrug resistance in cancer
    Yehuda G. Assaraf, Anamaria Brozovic, Ana Cristina Gonçalves, Dana Jurkovicova, Aija Linē, Miguel Machuqueiro, Simona Saponara, Ana Bela Sarmento-Ribeiro, Cristina P.R. Xavier, M. Helena Vasconcelos
    Drug Resistance Updates.2019; 46: 100645.     CrossRef
  • The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective
    Silvia Batista, Ana C. Gregório, Andreia Hanada Otake, Nuno Couto, Bruno Costa-Silva
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • 10,696 View
  • 297 Download
  • 32 Web of Science
  • 30 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP